Fischer, K. Et Al. 2024. Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS). Research and Practice in Thrombosis and Haemostasis , vol.8, no.4 .

Fischer, K., Lassila, R., Peyvandi, F., Gatt, A., Gouw, S. C., Hollingsworth, R., ... Lambert, T.(2024). Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS). Research and Practice in Thrombosis and Haemostasis , vol.8, no.4.

Fischer, Kathelijn Et Al. "Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)," Research and Practice in Thrombosis and Haemostasis , vol.8, no.4, 2024

Fischer, Kathelijn Et Al. "Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)." Research and Practice in Thrombosis and Haemostasis , vol.8, no.4, 2024

Fischer, K. Et Al. (2024) . "Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)." Research and Practice in Thrombosis and Haemostasis , vol.8, no.4.

@article{article, author={Kathelijn Fischer Et Al. }, title={Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)}, journal={Research and Practice in Thrombosis and Haemostasis}, year=2024}